van Kessel A G, Tetteroo P, van Agthoven T, Paulussen R, van Dongen J, Hagemeijer A, von dem Borne A
J Immunol. 1984 Sep;133(3):1265-9.
Human x mouse myeloid cell hybrids were obtained after fusion of human leucocytes and the murine myeloid cell line WEHI-TG. The hybrids were tested for reactivity with a panel of monoclonal antibodies with a known myelocytic, monocytic, or myelomonocytic specificity. Twenty antibodies, all of which bind specifically to the surface of human myeloid cells, exhibited very similar reactivity patterns with the hybrid clones. Chromosomal analysis of hybrid cell metaphases revealed that the gene(s) involved in the expression of the antigen(s) recognized by these antibodies must be located on human chromosome 11 in the region q12-qter. These results are compatible with the evidence obtained from other studies that several, if not all, of the myeloid-specific antibodies used are reactive with a similar antigenic determinant present on human myeloid cells.
人白细胞与鼠骨髓细胞系WEHI-TG融合后获得了人-鼠骨髓细胞杂种。用一组具有已知髓细胞、单核细胞或髓单核细胞特异性的单克隆抗体检测这些杂种的反应性。所有20种抗体都能特异性结合人骨髓细胞表面,它们与杂种克隆表现出非常相似的反应模式。对杂种细胞中期进行染色体分析发现,这些抗体所识别抗原的表达相关基因一定位于人类11号染色体的q12-qter区域。这些结果与其他研究所得证据相符,即所使用的几种(如果不是全部的话)髓系特异性抗体与人类骨髓细胞上存在的相似抗原决定簇发生反应。